instruction:
Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.
question:
Paragraph: The Supreme Judicial Court said MIT cannot be blamed for the death of 25-year-old Han Nguyen, who jumped from the top of a campus building minutes after a professor confronted him about an offensive email. But it found that schools can be liable if they fail to act after they become aware that a student has attempted suicide while enrolled, or shortly before entering, or learn that the student had threatened to commit suicide. Gary Pavela, a consultant on law and policy issues in higher education, said he’s unaware of another state appellate court that has explicitly found that universities have a duty to prevent suicide in limited cases and defines those circumstances. “This will be very newsworthy to colleges around the country,” said Pavela, who has written a book about the legal questions surrounding student suicides. Jeffrey Beeler, an attorney for Nguyen’s estate, said they were disappointed the court sided with MIT, but believe its ruling will nonetheless “save student lives going forward.” An MIT spokeswoman said in a statement that Nguyen’s death was a tragedy and students’ well-being is of “paramount importance to the school.” Spokeswoman Kimberly Allen said the school already offers a “robust network” of services for students and “continually considers ways to enhance those resources.” The court noted that Nguyen never told anyone at MIT that he planned to kill himself or tried to kill himself while enrolled at the school. Furthermore, he was living off campus instead of a dormitory under “daily observation,” the court said. But the judges said schools must take “reasonable measures” to help students they know have attempted suicide while at the school or have threatened to kill themselves. That would include initiating a suicide prevention protocol, getting the student in the care of a medical professional, or contacting police, fire or emergency medical personnel. “It requires the school to really have a lot of information that the suicide is likely and the reasonable measures that the school needs to take are not extremely onerous,” said Naomi Shatz, an attorney who’s not involved in the case. A group of 18 colleges and universities — including Harvard University and Boston College — told the court that holding MIT responsible for Nguyen’s death would have far-reaching consequences by causing officials with no medical expertise to overreact to concerns out of fear of liability. Nguyen’s professors shared concerns about his mental health in the months leading up to his death, and one encouraged his colleagues to pass him or they might have “blood on their hands.” In a telephone call 11 minutes before he killed himself, a professor “read him the riot act” over an email Nguyen sent to another MIT official that they believed was inappropriate, court records said. The family said that the school should have known that “mishandling this fragile student” would result in his suicide. But MIT said the school wasn’t aware of the severity of his condition, noting that he was treated by outside professionals and refused on-campus resources. None of the professionals who treated Nguyen while he was at MIT believed he was an imminent risk of killing himself, the school said. ___ Follow Alanna Durkin Richer at http://twitter.com/aedurkinricher . Read more of her work at http://bit.ly/2hIhzDb . Claim: Court says schools can be liable for suicides but clears MIT.
answer:
Schools can be held liable for student suicides in certain circumstances, Massachusetts’ highest court said Monday in a ruling that also cleared the Massachusetts Institute of Technology of responsibility for the death of a graduate student who killed himself on campus in 2009.


question:
Paragraph: "For the third year in a row, the Milwaukee Brewers’ lights-out closer John Axford faced a challenge when it came to getting to spring training on time. In 2010, it was an auto accident; in 2011 a case of food poisoning. This season it was red tape involving his 8-month-old son, J.B., also known to Axford’s Twitter followers as ""Little Ax."" The boy was born in Milwaukee, and is a U.S. citizen. The elder Axford, however, is a Canadian. And his trip to Arizona was delayed because he didn’t have a passport for the baby when he was planning to fly from Canada into the United States. His Twitter followers (@JohnAxford) got a play-by-play of his travel travails. Among the offerings: ""Thank you Homeland Security for not letting my AMERICAN son into AMERICA! #3YearValentinesCurse #WontBeSeeingYouTodayWarmWeatherInPhoenix""  He was more expansive in an interview with the Journal Sentinel, which is what prompted us to turn our version of the radar gun -- the Truth-O-Meter -- on Axford. ""Homeland Security requires passports for every age, no matter what,"" Axford said in the interview. ""You can arrive by land or sea if you're under the age of 15 with a birth certificate, but if you go by air Homeland Security requires passports for everybody, no matter what the age."" Is he right? Passports only by air, though birth certificates suffice by car or boat? Now, it’s  Axford is a sports figure. But his statement touches squarely on U.S. policy. So we checked with the State Department, Homeland Security, border control and several federal government websites. Turns out the rules are different for border-crossing babies, depending on the mode of travel. If you’re traveling by air, you need a passport. Period. And, yes, you have to get a photograph of the kid. A kid passport costs $105. However, if you’re coming by land -- such as the border crossing in Detroit -- the rules are less strict, and less expensive. ""U.S. children ages 15 and under arriving by land or sea from a contiguous territory may present an original or copy of his or her birth certificate (issued by the Vital Records Department in the state where he or she was born), a Consular Report of Birth Abroad, or a Naturalization Certificate. If the child is a newborn and the actual birth certificate has not arrived from the Vital Records Department, we will accept a Hospital issued birth certificate."" Each year, the federal government issues about 450,000 passports to infants, a spokeswoman for the State Department said in an email. The department even provides helpful hints for how to take a passport picture of your little one. Kiddie passports are valid for five years. In the end, Axford got to spring training the hard way, again. His father drove the family across the border to Detroit and they caught a flight from there to Arizona. Our conclusion  Axford’s trip back to the mound took a detour. He said it was because of travel delays and said federal law required his baby to have a passport to fly back into the country. He learned a valuable lesson about border crossing: The feds are always right." Claim: All travelers -- even babies -- arriving in the U.S. by air must have a passport.
answer:
Milwaukee Brewers pitcher John Axford says even babies need a passport to enter the U.S. by air


question:
Paragraph: Luke Miels, who joined GSK in September 2017 after a contract dispute with his former employer AstraZeneca, said picking the most promising projects and developing them quickly now takes precedence over spreading the risk of failure. “In the past, 10 programs were chosen, a budget for eight was allocated. Usually what happened was that time was the trade off that was made,” he said in an interview. “Now what we do is we pick five or six programs, and concentrate investment there.”   GSK, like rivals, was in the habit of testing new drugs first on patients who had run out of other treatment options. If successful, it would try patients at an earlier stage of their disease, replacing older, established treatments. In today’s market, where rivals in the United States and China catch up fast if a new class of drug shows promise, GSK has to run costly drug tests on humans in several settings at the same time, even if it means dropping other drug candidates. “Rather than do things sequentially, you do them in parallel, or as close to parallel as possible,” Miels said. GSK, which is battling to return to profit growth, has taken this approach for instance with an experimental drug that for now goes by the code name of GSK’916 against multiple myeloma, a common and incurable type of blood cancer. Likewise, GSK doubled down on its quest to bring a drug known as GSK’165 to market as a rheumatoid arthritis treatment, even after initial results in a mid-stage drug trial did not show a clear enough reading. “This drug has very interesting effects on pain. That could potentially reduce the use of opioids and pain meds,” Miels said. More trials will be run to make the pain argument more clearly, he added. GSK expects a decline of 5%-9% in adjusted earnings per share this year, excluding exchange rate moves, as it suffers from generic competition to its inhalable lung drug Advair and pressure from rival Gilead in HIV treatments. Miels said a tougher stance on drug prices by U.S. lawmakers and medical insurers was one of the reasons for the need for speed in bringing drugs to market - to try to remain ahead of competitors for as long as possible. At the same time, rapid growth in the Chinese market was spurring a more sophisticated healthcare system there, with local biotech groups quick to catch up with Western pioneers in drug development, producing similar drugs for their home market. Claim: GSK pharma head flags need for speed in high-pressure drug market.
answer:

Doing things one at a time in drug development is not a luxury that GlaxoSmithKline can afford any longer, the head of pharmaceuticals at Britain’s largest drugmaker told Reuters.